Ohio Public Employees Retirement System (OPERS)’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-28,787
| Closed | -$626K | – | 2379 |
|
|
2026
Q1 | $626K | Buy |
28,787
+875
| +3% | +$16.9K | ﹤0.01% | 1425 |
|
|
2025
Q4 | $601K | Sell |
27,912
-1,059
| -4% | -$22.3K | ﹤0.01% | 1464 |
|
|
2025
Q3 | $558K | Buy |
28,971
+179
| +0.6% | +$3.19K | ﹤0.01% | 1492 |
|
|
2025
Q2 | $492K | Buy |
28,792
+607
| +2% | +$25.9K | ﹤0.01% | 1498 |
|
|
2025
Q1 | $1.8M | Sell |
28,185
-2,925
| -9% | -$308K | 0.01% | 1124 |
|
|
2024
Q4 | $3.78M | Sell |
31,110
-1,782
| -5% | -$218K | 0.01% | 826 |
|
|
2024
Q3 | $4.11M | Sell |
32,892
-1,638
| -5% | -$226K | 0.02% | 740 |
|
|
2024
Q2 | $5.46M | Buy |
34,530
+296
| +0.9% | +$38K | 0.02% | 564 |
|
|
2024
Q1 | $4.43M | Sell |
34,234
-3,227
| -9% | -$395K | 0.02% | 663 |
|
|
2023
Q4 | $3.61M | Sell |
37,461
-2,684
| -7% | -$257K | 0.01% | 779 |
|
|
2023
Q3 | $4.87M | Sell |
40,145
-4,036
| -9% | -$456K | 0.02% | 587 |
|
|
2023
Q2 | $5.06M | Sell |
44,181
-507
| -1% | -$65.4K | 0.02% | 612 |
|
|
2023
Q1 | $6.16M | Buy |
44,688
+1,552
| +4% | +$201K | 0.03% | 538 |
|
|
2022
Q4 | $5.59M | Buy |
43,136
+904
| +2% | +$105K | 0.02% | 565 |
|
|
2022
Q3 | $4.67M | Buy |
42,232
+333
| +0.8% | +$33.6K | 0.02% | 644 |
|
|
2022
Q2 | $3.14M | Sell |
41,899
-1,387
| -3% | -$102K | 0.01% | 868 |
|
|
2022
Q1 | $3.38M | Sell |
43,286
-1,510
| -3% | -$116K | 0.01% | 912 |
|
|
2021
Q4 | $4.03M | Buy |
44,796
+79
| +0.2% | +$6.75K | 0.01% | 867 |
|
|
2021
Q3 | $4.13M | Sell |
44,717
-815
| -2% | -$62.8K | 0.01% | 852 |
|
|
2021
Q2 | $3.54M | Buy |
45,532
+5,528
| +14% | +$419K | 0.01% | 933 |
|
|
2021
Q1 | $2.98M | Buy |
40,004
+2,994
| +8% | +$276K | 0.01% | 929 |
|
|
2020
Q4 | $6.31M | Buy |
37,010
+7,499
| +25% | +$1.11M | 0.03% | 538 |
|
|
2020
Q3 | $4.14M | Buy |
29,511
+1,123
| +4% | +$171K | 0.02% | 570 |
|
|
2020
Q2 | $4.55M | Buy |
28,388
+817
| +3% | +$111K | 0.03% | 562 |
|
|
2020
Q1 | $2.7M | Buy |
27,571
+3,377
| +14% | +$386K | 0.02% | 707 |
|
|
2019
Q4 | $3.12M | Sell |
24,194
-13,752
| -36% | -$1.39M | 0.02% | 755 |
|
|
2019
Q3 | $2.86M | Buy |
37,946
+61
| +0.2% | +$7.2K | 0.02% | 810 |
|
|
2019
Q2 | $5.76M | Sell |
37,885
-1,705
| -4% | -$207K | 0.03% | 481 |
|
|
2019
Q1 | $4.72M | Sell |
39,590
-4,688
| -11% | -$603K | 0.02% | 609 |
|
|
2018
Q4 | $4.83M | Sell |
44,278
-3,531
| -7% | -$442K | 0.03% | 529 |
|
|
2018
Q3 | $7.72M | Buy |
47,809
+8,286
| +21% | +$1.13M | 0.04% | 447 |
|
|
2018
Q2 | $5.22M | Buy |
+39,523
| New | +$3.73M | 0.03% | 616 |
|
Other funds holding SRPT
EAM
Ohio Public Employees Retirement System (OPERS)'s SRPT Position: Q2 2026 in Review
Ohio Public Employees Retirement System (OPERS) sold out of Sarepta Therapeutics (SRPT) in Q2 2026, closing a stake of 28,787 shares — an estimated $626K sold.
Ohio Public Employees Retirement System (OPERS) first reported a position in SRPT in Q2 2018 and held it in 32 quarters. The position peaked at $7.72M in Q3 2018. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.
- Ohio Public Employees Retirement System (OPERS) reported no remaining Sarepta Therapeutics position as of Q2 2026 after selling out during the quarter.
- Ohio Public Employees Retirement System (OPERS) sold 28,787 Sarepta Therapeutics shares in Q2 2026, an estimated $626K.
- Ohio Public Employees Retirement System (OPERS) first reported a position in Sarepta Therapeutics in Q2 2018 and held it in 32 quarters.
- Ohio Public Employees Retirement System (OPERS)'s Sarepta Therapeutics position peaked at $7.72M in Q3 2018.
- 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.
Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.